Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

KFM19

Catalog No. T15655 Copy Product Info
Purity: 98.62%
😃Good
KFM19 is a potent and selective adenosine receptor (A1-receptor) antagonist (IC50 : 50 nM) for the study of neurological disorders.

KFM19

Copy Product Info
😃Good
Catalog No. T15655

KFM19 is a potent and selective adenosine receptor (A1-receptor) antagonist (IC50 : 50 nM) for the study of neurological disorders.

KFM19
Cas No. 133058-72-7
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$42In StockIn Stock
5 mg$95In StockIn Stock
10 mg$138In StockIn Stock
25 mg$260In StockIn Stock
50 mg$383In StockIn Stock
100 mg$545In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.62%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

KFM19 AI Summary
KFM19 demonstrates a high binding affinity towards the bovine Adenosine A1 receptor with a Ki value of 15.0 nM. It also binds to the Adenosine A2 receptor with a lower affinity, indicated by a Ki value of 2700.0 nM, yielding a binding ratio of A2 to A1 of 180.0. The compound's solubility is measured at 220.0 µg/mL in water and 200.0 µg/mL in saline. Additionally, KFM19 exhibits antagonistic activity in avoidance tests induced by Scopolamine and (R)-PIA in both rats and mice. It was also tested for locomotor activity at doses of 2.5 mg/kg and 10 mg/kg, showing increasing counts over a 120-minute period..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
KFM19 is a potent and selective adenosine receptor (A1-receptor) antagonist (IC50 : 50 nM) for the study of neurological disorders.
Targets&IC50
Adenosine receptor:50 nM
Chemical Properties
Molecular Weight318.37
FormulaC16H22N4O3
Cas No.133058-72-7
SmilesCCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)C1CCC(=O)C1
Relative Density.1.268g/cm3
Storage & Solubility Information
Storage02 | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (251.28 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1410 mL15.7050 mL31.4100 mL157.0500 mL
5 mM0.6282 mL3.1410 mL6.2820 mL31.4100 mL
10 mM0.3141 mL1.5705 mL3.1410 mL15.7050 mL
20 mM0.1570 mL0.7852 mL1.5705 mL7.8525 mL
50 mM0.0628 mL0.3141 mL0.6282 mL3.1410 mL
100 mM0.0314 mL0.1570 mL0.3141 mL1.5705 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy KFM19 | purchase KFM19 | KFM19 cost | order KFM19 | KFM19 chemical structure | KFM19 formula | KFM19 molecular weight